A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial

(2014) D.D. Rhoads et al.   Journal of Wound Care

Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications

(2013) Zuzanna Drulis-Kawa et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Clinical relevance of the ESKAPE pathogens

(2013) Jack N Pendleton et al.   Expert Review of Anti-Infective Therapy

Bacteriophage Therapy in Implant-Related Infections

(2013) Cengiz Yilmaz et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Phage therapy of Cronobacter-induced urinary tract infection in mice

(2013) Lubomira Tothova et al.   MEDICAL SCIENCE MONITOR

Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15

(2012) Flavie Pouillot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prokaryote viruses studied by electron microscopy

(2012) H.-W. Ackermann et al.   ARCHIVES OF VIROLOGY

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

(2012) Eva Morales et al.   BMC HEALTH SERVICES RESEARCH

 2GFP10, a High-Intensity Fluorophage, Enables Detection and Rapid Drug Susceptibility Testing of Mycobacterium tuberculosis Directly from Sputum Samples

(2012) P. Jain et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Turning a new phage

(2012) Lauren Gravitz   NATURE MEDICINE

Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany

(2012) Maia Merabishvili et al.   PLoS One

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh

(2012) Shafiqul Alam Sarker et al.   VIROLOGY

Bacteriophages and their Implications on Future Biotechnology: A Review

(2012) Irshad UL Haq et al.   Virology Journal

The Staphylococci Phages Family: An Overview

(2012) Marie Deghorain et al.   Viruses-Basel

Interaction of Bacteriophage l with Its E. coli Receptor, LamB

(2012) Sujoy Chatterjee et al.   Viruses-Basel

Bacteriophages  MR299-2 and  NH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells

(2012) D. Alemayehu et al.   mBio

Experimental Phage Therapy in TreatingKlebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in Mice

(2011) Chih-Hsin Hung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes

(2011) Rotem Edgar et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The antibiotic R&D pipeline: an update

(2011) Daniela Jabes   CURRENT OPINION IN MICROBIOLOGY

Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now

(2011) Laura Freire-Moran et al.   DRUG RESISTANCE UPDATES

The influence of external factors on bacteriophages—review

(2011) E. Jończyk et al.   FOLIA MICROBIOLOGICA

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention

(2011) Eric Morello et al.   PLoS One

Bacteriophages as biocontrol agents of food pathogens

(2010) Jennifer Mahony et al.   CURRENT OPINION IN BIOTECHNOLOGY

Designing Phage Therapeutics

(2010) Lawrence Goodridge   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Phage Therapy in Clinical Practice: Treatment of Human Infections

(2010) Elizabeth Kutter et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Bacteriophages ofPseudomonas

(2010) Pieter-Jan Ceyssens et al.   Future Microbiology

Multidrug-resistant Gram-negative bacteria: how to treat and for how long

(2010) Helen Giamarellou   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Bacteriophages Can Treat and PreventPseudomonas aeruginosaLung Infections

(2010) Laurent Debarbieux et al.   JOURNAL OF INFECTIOUS DISEASES

Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055

(2010) S. Kumari et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

(2010) Jean-Paul Pirnay et al.   PHARMACEUTICAL RESEARCH

Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice

(2010) Raju Sunagar et al.   RESEARCH IN MICROBIOLOGY

A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses

(2009) Ryszard Międzybrodzki et al.   CLINICAL AND EXPERIMENTAL MEDICINE

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice

(2009) CS Vinodkumar et al.   Indian Journal of Pathology and Microbiology

Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge

(2009) Cesar A. Arias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

(2009) Maya Merabishvili et al.   PLoS One

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

(2009) T. K. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bacteriophage biocontrol in animals and meat products

(2009) R. J. Atterbury   Microbial Biotechnology

Bacteriophage genomics

(2008) Graham F Hatfull   CURRENT OPINION IN MICROBIOLOGY

The Use of Phages for the Removal of Infectious Biofilms

(2008) J. Azeredo et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY